OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Proteomics
(1)
Organisms
Mus musculus
(1)
Repository
pride
(1)
Tissue
Brain
(1)
Epithelial cell
(1)
Skin
(1)
Disease
Melanoma
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2020
(1)
Release Date
2021
(3)
2016
(3)
2025
(2)
2018
(2)
2013
(2)
2024
(1)
2022
(1)
2020
(1)
2019
(1)
2017
(1)
Lab affiliation
Centre for Tumor Biology, Barts Cancer Institute – a CR-UK Centre of Excellence, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, United Kingdom
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.
Not available
S-EPMC6141244
|
biostudies-literature
Cite
Intensive Surveillance and Aggressive Multimodal Treatment for Liver Metastases From Uveal Melanoma.
Not available
S-EPMC12727333
|
biostudies-literature
Cite
Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells.
Not available
S-EPMC4108060
|
biostudies-literature
Cite
Role of 3'-Deoxy-3'-[<sup>18</sup>F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase.
Not available
S-EPMC9445378
|
biostudies-literature
Cite
Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1.
Not available
S-EPMC4978703
|
biostudies-literature
Cite
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.
Not available
S-EPMC3563985
|
biostudies-literature
Cite
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Not available
S-EPMC8560642
|
biostudies-literature
Cite
Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM.
Not available
S-EPMC6294248
|
biostudies-literature
Cite
Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1-Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms.
Not available
S-EPMC8474273
|
biostudies-literature
Cite
CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial.
Not available
S-EPMC5907297
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
